[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:primitive-neuroectodermal-tumor":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":33,"states":34},"Primitive Neuroectodermal Tumor",4,[7,15,21,27],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT03911388","HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors",[11],"Phase 1","RECRUITING","2026-08-26T02:16:16.169331Z","2026-07-30T01:46:14.458417Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":19,"content_modified":20},"NCT02508038","Alpha\u002FBeta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors",[11],"2026-08-26T02:17:26.640202Z","2026-05-05T02:43:29.192915Z",{"nct_id":22,"title":23,"phases":24,"status":12,"updated_at":25,"content_modified":26},"NCT04541082","Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms",[11],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:29.163334Z",{"nct_id":28,"title":29,"phases":30,"status":12,"updated_at":31,"content_modified":32},"NCT04185038","Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma\u002FDiffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors",[11],"2026-08-26T02:18:51.833592Z","2026-05-05T02:43:28.903254Z",[],[]]